Smoking Cessation Products Market

Global Smoking Cessation Products Market Outlook (2022-2032)

The global smoking cessation products market is estimated at USD 24 Billion in 2022 and is forecast to surpass USD 57 Billion by 2032, growing at a CAGR of 9.2% during 2022-2032.

Report Attributes	Details
Base Year Value (2021A)	USD 22 Billion
Estimated Year Value (2022E)	USD 24 Billion
Projected Year Value (2032F)	USD 57 Billion
Global Growth Rate (2022-2032)	9.2%
North America Market Share in 2021	23.9%
North America Growth Rate in 2021	10.9%
Collective Value Share (US, China, India) 2022: Top 3 Countries	~31%
Top 5 Companies Market Share	~22%
Key Companies Profiled	Johnson & Johnson Inc. GlaxoSmithKline plc Pfizer Inc. Perrigo Company plc Cipla Ltd ITC Limited Reynolds American Inc. Imperial Tobacco Ltd. Fertin Pharma Alkalon A/S Fontem Ventures Nicotek LLC Novartis British American Tobacco PLC Smoke Away The Harvard Drug Group VMR Products LLC

The global smoking cessation products market accounts for ~3% of the global smoking market in 2022. The global smoking cessation products market is estimated to have an absolute $ opportunity of USD 33 Billion during the assessment period of 2022-2032.

Stringent Smoke-free Air Laws Triggering Smoking Cessation Products Market Growth

The market is expected to show positive growth rate due to smoke-free air laws which are aimed at restricting exposure of minors to smoking products and protect consumers from second-hand smoking. These laws are imposed by various organizations and governments of particular countries. For instance, United States banned smoking in most public places under the Department of Health Functions Clarification Amendment Act of 2006.

Thus, growth prospects of cessation products market are attributed to these smoke-free air laws which limit promoting and advertising of tobacco products and exhort smoker population to quit smoking using smoking cessation products. Thus, the market is expected to witness 1.7X more demand in coming years.

Growing COPD Diseases Driving Demand

Tobacco smoking is the primary cause of Chronic Obstructive Pulmonary Disease (COPD). According to World Health Organization (WHO), more than 260 million patients across the world are suffering from Chronic Obstructive Pulmonary Disease and it is likely to become third leading cause of death by the end of 2030.

As there is no cure for this life-threatening disease, demand for smoking cessation products is rising at a rapid pace. Thus, consumer awareness is leading to market growth by approximately 23%.

Manufacturers in smoking cessation products market are offering personalized smoking cessation products to help patients with COPD management, thus improving sales of smoking cessation products in coming years.

Escalating Tobacco Related Deaths Thriving Market Growth

According to World Health Organization, tobacco smoking kills more than 8 million consumers every year. Amongst them, 7 million deaths are caused by direct tobacco use and rest are caused by exposure to second-hand smoke, making it one of the leading causes of deaths in the world. 

Increasing awareness about the significant negative health hazards of tobacco consumption is exhorting consumers to quit smoking. The trend to quit smoking is high amongst pregnant and lactating women, because of substantial negative impact on child and the mother. Therefore, smoking cessation products which reduces the incidences of tobacco-related illnesses and removes the urge to smoke is poised to provide a gain of 230 BPS during the forecast period of 2022-2032.

Fact.MR projects the smoking cessation products market to witness exhibiting growth at 9.2% CAGR between 2022 and 2032 in comparison to a CAGR of 4.8% posted between 2017 and 2021.

Regulations on Cessation Products Creating Challenges

Certain laws and regulations regarding the marketing and distribution of smoking cessation products has been laid down by governmental organizations to address public health concern with use of tobacco and products like electronic cigarettes. For instance, Family Smoking Prevention and Tobacco Control Act was amended by Food and Drug Administration (FDA) of United States.

It declared that smoking cessation products and vaping products will be subject to the Federal Food, Drug, and Cosmetic Act.

Canadian Government also enacted the Tobacco and Vaping Products Act (TVPA) to regulate the manufacturing and sales of smoking cessation products like e-cigarettes in Canada. In addition to this, the United Kingdom (UK) government introduced rules to regulate smoking cessation products under the Tobacco Products Directive (TPD).

All the above listed laws and regulations in leading countries is likely to create barriers for manufacturing, marketing and distribution of smoking cessation products during the forecast period of 2022-2032.

Potential Risks Driving Consumers Away

Although smoking cessation products help consumers quit smoking but they do come with certain side effects that may lead to consumer discomfort. Products like patches, nasal sprays etc. may cause irritation in eyes, nose, throat or skin and may sometimes lead to behavioral changes in consumers.

Additionally, varenicline and bupropion, smoking cessation products may lead to insomnia and diarrhea as a side-effect amongst consumers. Rising consumer awareness about the risks of use of smoking cessation products may hamper growth of the market.

Region-wise Insights

How much revenue is contributed by developed regions in Smoking Cessation Products Market?

Though the use of smoking cessation products is ubiquitous across the globe, but North America and Europe smoking cessation products market account for more than 80% of overall revenue, according to the Fact.MR study.

Tobacco smoking has reached to new high levels in U.S. and Europe, due to alarming adoption of tobacco products amongst youth and adult population. However, the regions are witnessing an increase in quitting, where North America and Europe contributes nearly 23.9% and 21.5% to the smoking cessation products market in 2021.

What is the market scenario in the Asia-Pacific?

East Asia and South Asia holds 37.8% of the overall market share, respectively. This is attributed to growing awareness about the smoking cessation products and nicotine de-addiction products amongst the consumer base.  

Asia is the world’s largest tobacco consumer and producer and approximately more than half of the world’s male smokers live in India, China and Indonesia. Thus, there lies lucrative opportunities for manufacturers in Asia-Pacific smoking cessation products market which is expected to grow at 7.2% CAGR during the assessment period of 2022-2032.

Country-wise Insights

How the market scenario has changed in New Zealand in recent years?

New Zealand in year 2021 banned the sale of tobacco products to have a tobacco-free generation. The law is likely to reduce access to tobacco and constrain nicotine levels in cigarettes, which is expected to help people to quit smoking.

This presents profitable opportunity for manufacturers to offer smoking cessation products in the country by expanding their reach. This is poised to raise their revenue by 1/6th of current revenue levels.

Category-wise Insights

What are the key insights on therapy segment in Smoking Cessation Products Market?

Nicotine Replacement Therapy (NRT) holds more than 38% of global market share because it is more effective to quit smoking. NRT produces a robust increase in quit rates as compared to other effective treatments available in the market.

However, most customers are adopting e-cigarettes as a smoking cessation product as a recent trend. E-cigarettes are an effective and healthy alternative to tobacco cigarettes. The consumption of e-cigarettes is less harmful and is the major driving factor for the market. Thus, persistent popularity of e-cigarettes is expected to enhance growth in this segment by 1.1X in coming years.

Competitive Landscape: Top Companies in Smoking Cessation products Market

The global smoking cessation products market is highly fragmented and competitive owing to the existence of many domestic and regional players. Various marketing strategies are adopted by key players such as mergers and acquisitions, expansions, collaborations and partnerships.

Also, new product development as a strategic approach is adopted by the leading companies to upscale their market presence among consumers. These strategies have resulted in the incorporation of advanced smoking cessation products.

Fact.MR has provided detailed information about price points of top manufacturers of smoking cessation products positioned across regions, sales growth, production capacity, and speculative technological expansion in the recently published report.

For instance: Dr. Reddy’s Laboratories in 2020, launched Over-the-counter (OTC) Nicotine Polacrilex Lozenges in United States. The product offering reduces withdrawal symptoms like nicotine cravings and is an addition of Nicotine Replacement Therapy (NRT).

Global Smoking Cessation products Market by Category

• By Product Type :

  • Chewing Gum
  • Patches
  • Inhalers
  • Lozenges
  • Nasal Sprays

• By Therapy :

  • Nicotine Replacement Therapy (NRT)
  • Non-NRT Therapy
  • E-Cigarettes

• By Sales Channel :

  • Hospital Pharmacies
  • Drug Stores
  • Retail Stores
  • Online Stores

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA